Switch theme
Sign up to access all valuation multiples
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, it is operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.
2015
n/a
Last FY Revenue $96.9M
Last FY EBITDA -$0.5M
$144M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, BlueMTec achieved revenue of $96.9M and an EBITDA of -$0.5M.
BlueMTec expects next 12-month revenue of XXX and NTM EBITDA of XXX
See BlueMTec valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $96.9M | XXX | XXX | XXX |
| Gross Profit | XXX | $9.7M | XXX | XXX | XXX |
| Gross Margin | XXX | 10% | XXX | XXX | XXX |
| EBITDA | XXX | -$0.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 0% | XXX | XXX | XXX |
| EBIT | XXX | -$5.0M | XXX | XXX | XXX |
| EBIT Margin | XXX | -5% | XXX | XXX | XXX |
| Net Profit | XXX | -$3.5M | XXX | XXX | XXX |
| Net Margin | XXX | -4% | XXX | XXX | XXX |
| Net Debt | XXX | $12.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, BlueMTec's stock price is KRW 5320 (or $4).
BlueMTec has current market cap of KRW 178B (or $130M), and EV of KRW 198B (or $144M).
See BlueMTec trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $144M | $130M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, BlueMTec has market cap of $130M and EV of $144M.
BlueMTec's trades at 1.5x EV/Revenue multiple, and -298.5x EV/EBITDA.
Equity research analysts estimate BlueMTec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BlueMTec's P/E ratio is not available.
See valuation multiples for BlueMTec and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $130M | XXX | $130M | XXX | XXX | XXX |
| EV (current) | $144M | XXX | $144M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -298.5x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -28.7x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -37.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -13.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBlueMTec's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
BlueMTec's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BlueMTec's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for BlueMTec and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 0% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BlueMTec acquired XXX companies to date.
Last acquisition by BlueMTec was XXXXXXXX, XXXXX XXXXX XXXXXX . BlueMTec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was BlueMTec founded? | BlueMTec was founded in 2015. |
| Where is BlueMTec headquartered? | BlueMTec is headquartered in South Korea. |
| Is BlueMTec publicy listed? | Yes, BlueMTec is a public company listed on KRX. |
| What is the stock symbol of BlueMTec? | BlueMTec trades under 439580 ticker. |
| When did BlueMTec go public? | BlueMTec went public in 2023. |
| Who are competitors of BlueMTec? | Similar companies to BlueMTec include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of BlueMTec? | BlueMTec's current market cap is $130M |
| Is BlueMTec profitable? | Yes, BlueMTec is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
